Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
5
×
pfizer
5
×
biotech
boston blog main
boston top stories
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
amgen
breast cancer
clinical trials
gene therapy
immunotherapy
national
san francisco blog main
san francisco top stories
spark therapeutics
abbvie
adverum biotechnologies
akcea therapeutics
albert bourla
alzheimer's disease
american cancer society
amicus therapeutics
anylam pharmaceuticals
artificial intelligence
arvinas
avelumab
batten disease
bayer
big pharma
biogen
biomarin
biovex
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
What
pfizer
drug
approved
bio
ceo
patients
acquisitions
ago
akcea
albert
alex
alnylam
amyloidosis
announced
attr
available
battle
biggest
bourla
cancer
close
collaboration
combo
companies
company
crispr
data
dating
debilitating
discovery
disease
entered
fda
forward
future
game
gene
genetic
happening
heated
Language
unknown
unset
Current search:
pfizer���s
×
pfizer
×
" national blog main "
×
@xconomy.com
4 years ago
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com
4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea